Geftilon 250 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Geftilon 250 mg Tablet contains gefitinib, an EGFR tyrosine kinase inhibitor. Its labelling describes it for the treatment of metastatic non-small cell lung cancer in adults, including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. It is described as blocking the epidermal growth factor receptor (EGFR) protein that controls cancer-cell growth in lung tissues and other body parts, lowering their survival. The doctor may request a liver function test to monitor the organ.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the management of adults with metastatic non-small cell lung cancer
- Described as also prescribed for adenocarcinoma, squamous cell carcinoma, and large cell carcinoma
- Described as blocking the EGFR protein that controls cancer-cell growth in lung tissues and other body parts
Described Dosage & Administration
- The doctor’s instructions should be followed
- Swallowed with a glass of water
- The doctor may request a liver function test to monitor the organ
Described Side Effects
Commonly described side effects include:
- Diarrhoea
- Nausea and vomiting
- Skin reactions (acne-like rash)
- Loss of appetite
- Weakness
- Red, sore, or dry mouth
- Dry, red, or itchy eyes
- Nail problems
- Hair loss
- Fever
These are described as commonly temporary. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- The tablet should be avoided by anyone allergic to gefitinib
- The doctor should be informed beforehand of any kidney or liver issues
- Not for use in pregnant or breastfeeding women or in children below 18 years
- A liver function test may be requested to monitor the organ
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains gefitinib and is used for the treatment of metastatic non-small cell lung cancer in adults. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as swallowed with a glass of water, following the doctor’s instructions, with a liver function test possibly requested for monitoring.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.